Sign In
Buy CMPS
$12.69
-0.640 (-4.80%)
At Close: Jun 03, 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Critical Comparison: COMPASS Pathways (NASDAQ:CMPS) & Beauty Health (NASDAQ:SKIN)
02:10am, Sunday, 30'th Nov 2025
Beauty Health (NASDAQ: SKIN - Get Free Report) and COMPASS Pathways (NASDAQ: CMPS - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two com
Contrasting CVS Health (NYSE:CVS) and COMPASS Pathways (NASDAQ:CMPS)
02:32am, Friday, 21'st Nov 2025
CVS Health (NYSE: CVS - Get Free Report) and COMPASS Pathways (NASDAQ: CMPS - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based
Compass Pathways to Participate in Two Investor Conferences in December
06:30am, Thursday, 20'th Nov 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways to Participate in Stifel 2025 Healthcare Conference
06:30am, Wednesday, 05'th Nov 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
COMPASS Pathways plc (CMPS) Q3 2025 Earnings Call Transcript
11:16am, Tuesday, 04'th Nov 2025
COMPASS Pathways plc ( CMPS ) Q3 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants Stephen Schultz - Senior Vice President of Investor Relations Kabir Nath - CEO & Director Teri Lox
Compass Pathways to expedite launch timing of its experimental depression therapy
06:45am, Tuesday, 04'th Nov 2025
Drug developer Compass Pathways said on Tuesday it is pulling forward the expected launch timing of its experimental psilocybin-based depression therapy by 9 to 12 months.
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression
08:30am, Thursday, 30'th Oct 2025
Collaboration will leverage AI-powered neural analysis and Compass' expertise in psychedelic drug development to advance new therapies for mental health KEARNY, N.J. , Oct. 30, 2025 /PRNewswire/ -- Ne
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors
06:30am, Wednesday, 29'th Oct 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025
06:30am, Tuesday, 28'th Oct 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
COMPASS Pathways Plc (CMPS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
02:03pm, Tuesday, 09'th Sep 2025
COMPASS Pathways plc (NASDAQ:CMPS ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 10:45 AM EDT Company Participants Kabir Nath - CEO & Director Guy Goodwin - Chief Medical
COMPASS Pathways Plc (CMPS) Presents At Cantor Global Healthcare Conference 2025 Transcript
04:56am, Thursday, 04'th Sep 2025
COMPASS Pathways plc (NASDAQ:CMPS ) Cantor Global Healthcare Conference 2025 September 3, 2025 1:35 PM EDT Company Participants Kabir Nath - CEO & Director Guy Goodwin - Chief Medical Officer Steve Le
Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder
06:30am, Tuesday, 02'nd Sep 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways to Participate in Four Investor Conferences in September
06:30am, Wednesday, 27'th Aug 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
